GLUE vs REG · rev $13.2M vs P/E 34, rev $1.55B
Monte Rosa Therapeutics Inc (GLUE) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Monte Rosa Therapeutics Inc (GLUE) is a biotechnology company listed on NASDAQ.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported GLUE revenue for 2026-06-30 was $13.2M. Net income was -$87.9M. GLUE currently screens at market cap $1.56B.
Latest reported REG revenue for 2025-12-31 was $1.55B. Net income was $527.5M. Revenue was up 6.9% from 2024-12-31 to 2025-12-31. REG currently screens at market cap $12.93B and trailing P/E 33.5.
GLUE currently screens at market cap $1.56B. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the GLUE and REG stock pages for the full models.
Not investment advice.